Position in BCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,780
+$2,777 QoQ
Shares Held
278
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#290
of 316 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BESSEMER GROUP INC holds $260,223,140 across 27 Drug Manufacturers - Specialty & Generic names. BCRX ranks #26 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
5,581,600 | $189,104,601 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,857,221 | $26,911,129 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
186,321 | $8,803,899 | |
| 4 | ALKS |
Alkermes plc.
|
157,097 | $8,231,882 | |
| 5 | VTRS |
Viatris Inc
|
364,013 | $5,778,938 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
57,909 | $4,793,706 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
113,703 | $4,665,234 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
98,014 | $3,544,670 |
All Filings in BCRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,780 | 278 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $3 | 278 | Shares | Other | 2026-05-06 | |
| 2025-12-31 | $2,168 | 278 | Shares | Other | 2026-02-05 | |
| 2025-09-30 | $2,110 | 278 | Shares | Other | 2025-11-05 | |
| 2025-03-31 | $0 | 0 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $1 | 195 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1 | 195 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,573 | 740 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||